Indian Journal of Nephrology Home 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2022  |  Volume : 32  |  Issue : 4  |  Page : 327--333

Diabetes and mortality among patients with chronic kidney disease and COVID-19: A systematic review, meta-analysis, and meta-regression

Maria R Iryaningrum1, Rudi Supriyadi2, Sherly Lawrensia3, Joshua Henrina4, Nanny Natalia M. Soetedjo5 
1 Department of Internal Medicine, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
2 Department of Internal Medicine, Division of Nephrology and Hypertension, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia
3 Department of Medicine, Regional Public Hospital of Waikabubak, Tangerang, Indonesia
4 Department of Medicine, Balaraja Public Health Centre, Tangerang, Indonesia
5 Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran – Dr Hasan Sadikin Hospital, Bandung, Indonesia

Correspondence Address:
Maria R Iryaningrum
Address: Jl. Pluit Raya No. 2, RT.21/RW.8, Penjaringan, Kec. Penjaringan, Kota Jakarta Utara, Daerah Khusus Ibukota Jakarta - 14440
Indonesia

Introduction: Patients with kidney disease and COVID-19, whether on hemodialysis (HD) or not, have a higher risk of contracting COVID-19 accompanied by a higher mortality rate due to suppressed immune functions. Diabetes, one of the ubiquitous etiology of kidney disease, is also associated with a composite of poor outcomes. Methods: Meta-analysis and meta-regression of 13 articles on COVID-19 patients with chronic kidney disease, with information on diabetes and mortality were performed using Review Manager 5.4 and OpenMetaAnalyst. Results: The meta-analysis of a pooled subject of 18,822 patients showed that the presence of diabetes in CKD patients with COVID-19 was associated with an increased risk of mortality (RR 1.41 (1.15, 1.72); P < 0.001; I2 70%, P < 0.001). Subgroup analysis showed that diabetes was not associated with mortality in the HD group (RR 1.27 (1.06, 1.54); P = 0.01; I2 0%, P = 0.70) but showed a significant association in the non-HD group (RR 1.66 (1.59, 1.73); P < 0.001; I2 85%, P < 0.001). Male gender (P = 0.070) contributed to the effect size differences (age: P < 0.001; hypertension: P = 0.007; CVD: P < 0.001; lung disease: P < 0.001). Conclusions: Diabetes was associated with higher mortality risk among CKD patients, primarily those who did not need RRT.

How to cite this article:
Iryaningrum MR, Supriyadi R, Lawrensia S, Henrina J, M. Soetedjo NN. Diabetes and mortality among patients with chronic kidney disease and COVID-19: A systematic review, meta-analysis, and meta-regression.Indian J Nephrol 2022;32:327-333

How to cite this URL:
Iryaningrum MR, Supriyadi R, Lawrensia S, Henrina J, M. Soetedjo NN. Diabetes and mortality among patients with chronic kidney disease and COVID-19: A systematic review, meta-analysis, and meta-regression. Indian J Nephrol [serial online] 2022 [cited 2022 Sep 26 ];32:327-333
Available from: https://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2022;volume=32;issue=4;spage=327;epage=333;aulast=Iryaningrum;type=0